期刊文献+

Yes相关蛋白在前列腺癌中的表达及意义 被引量:4

Expression and significance of Yes-associated protein in prostate cancer
下载PDF
导出
摘要 目的:探讨Yes相关蛋白(Yes-associated protein,YAP)在前列腺癌(prostate cancer,PCa)组织、癌旁(pericarcinoma,PC)组织和良性前列腺增生(benign prostatic hyperplasia,BPH)组织中的表达差异及其意义。方法:采用免疫组化技术检测32例PCa,15例PC和15例BPH中YAP的表达情况;采用Western blot技术检测15例PCa和相应PC中YAP的表达水平。结果:32例PCa中YAP阳性表达25例,阳性率为78.13%;15例PC中YAP阳性表达4例,阳性率为26.67%;15例BPH中未发现YAP阳性表达。组间差异有统计学意义(P=0.000);YAP的表达与PCa的临床分期、Gleason评分有关(分别为P=0.019;P=0.012)。临床分期越高,Gleason评分越高,YAP的阳性率越高。Western blot显示15例PCa中YAP表达(0.723±0.084)均高于相应PC(0.455±0.161),差异具有统计学意义(P=0.006)。结论:YAP在PCa中的表达明显高于非肿瘤组织,表现出明显的肿瘤特异性,有望成为PCa临床诊断和治疗的一个新指标。 Objective :To investigate the expression and clinical significance of Yes-associated protein(YAP) in tissues of prostate can- cer (PCa), pericarcinoma (PC) and benign prostate hyperplasia (BPH). Methods: Expression of YAP protein of 32 cases of PCa, 15 cases of PC and 15 cases of BPH was investigated by immunohistochemistry. Moreover,different expression of YAP protein of 15 cas- es of PCa and its corresponding PC tissues were confirmed by Western blot. Results:Rate of YAP positive staining(78.13%, 25/32) in PCa tissues was higher than that in PC tissues(26.67%,4/15) and YAP positive staining was not seen in BPH tissues. Staining differ- ences between each group were statistically significant(P=0.000). Furthermore,different expression of YAP protein was relevant with clinical stage and degree of differentiation (P=0.019,P=0.012). The higher the clinical stage, the higher the Gleason score and YAP positive staining rate. Western blot demonstrated that YAP protein expression was higher in 15 cases of PCa(0.723 ±0.084) than in corresponding PC tissues (0.455 ± 0.161),with statistically significant differences (P=0.006). Conclusions:Expression of YAP protein is significantly higher in PCa tissues than in non-tumorous tissues, demonstrating obvious tumor specificity in PCa. YAP may be a new target in the diagnosis and treatment of PCa.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2014年第1期5-8,共4页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:30972999)
关键词 前列腺癌 Yes相关蛋白 免疫组化 蛋白质免疫印迹 prostate cancer Yes-associated protein immunohistochemistry Western blot
  • 相关文献

参考文献2

二级参考文献22

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献200

同被引文献41

  • 1Oudard S.Pregress in emerging therapies for advanced prostate can- cer[J].Cancer Treat Rev,2013,39(3) :275-289.
  • 2Jemal A,Bray F,Center MM,et al. Global Caneer Statisties[J].CA Cancer J Clin,2011,61(2) :69-90.
  • 3Petrylak DP.Current state of eastration-resistant?prostate cancer[J]. Am J Manag Care,2013,19( 18 sl ):s358-365.
  • 4Wang Q,Li W,Liu XS,et al.A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth[J]. Mol Cell, 2007,27(3) : 380-392.
  • 5Tran C, Ouk S, Clegg N J, et al.Development of a second-generation antiandrogen for treatment of advanced prostate cancer[J].Science,2009, 324(5928) : 787-790.
  • 6Bennett NC,Gardiner RA,Hooper JD,et al.Moleeular cell biology of androgen receptor signaling[J].Int J Biochem Cell Biol,2010,42(6): 813-827.
  • 7Xie Q,Chen J,Feng H,et al.YAP/TEAD-mediated transcription controls cellular senescence[J].Cancer Res, 2013,73 ( 12 ) : 3615- 3624.
  • 8Johnson R,Halder G.The two faces of Hippo:targeting the Hippo pathway for regenerative medicine and cancer treatment[J].Nat Rev Drug Discov, 2014,13 ( I ) : 63-79.
  • 9Tufail R,Jorda M,Zhao W,et al.Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas[J].Breast Cancer Res Treat, 2012, 131(3) :743-750.
  • 10Tanner MJ,Welliver RC Jr,Chen M,et al.Effects of androgen re- ceptor and androgen on gene expression in prostate stromal fibroblasts and paracrine signaling to prostate cancer cells[J].PLoS One,2011,6( 1 ) : e16027.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部